{"id":"intracervical-injection-of-vasopressin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Pallor"},{"rate":null,"effect":"Tremor"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vasopressin is a potent vasopressor agent that binds to V1 receptors on vascular smooth muscle, causing vasoconstriction. When injected intracervically, it reduces blood flow to the injection site and surrounding cervical tissue, thereby decreasing hemorrhage. This local hemostatic effect is utilized during gynecological procedures to minimize blood loss.","oneSentence":"Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:49:37.699Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage)"}]},"trialDetails":[{"nctId":"NCT07102615","phase":"PHASE4","title":"Intracervical Vasopressin","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Retained Products of Conception","enrollment":50},{"nctId":"NCT00816751","phase":"NA","title":"Paracervical Versus Intracervical Lidocaine","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2007-12","conditions":"Abortion, Induced, Pain","enrollment":89}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Intracervical injection of Vasopressin","genericName":"Intracervical injection of Vasopressin","companyName":"Prisma Health-Upstate","companyId":"prisma-health-upstate","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue. Used for Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}